Artiva Biotherapeutics, Inc. ARTV
CIK 0001817241
Form 3 statements with an event date from Nov 1, 2023 to Nov 8, 2026.
Where insider ownership starts.
Form 3 is an initial ownership statement filed when someone becomes a reporting insider. These holdings do not mean they bought shares that day.
| Holdings date | Insider | Initial holdings | |
|---|---|---|---|
| Oct 21, 2024 | MOORE ALISON Director | No securities reported | ▾ |
| Jul 18, 2024 | RA Capital Healthcare Fund LP · RA CAPITAL MANAGEMENT, L.P. · Kolchinsky Peter · Shah Rajeev M. · RA Capital Nexus Fund, L.P. Director · 10% owner / Director · 10% owner / Director · 10% owner / Director · 10% owner / Director | 5 derivative holdings | ▾ |
| Jul 18, 2024 | Schwab Andrew J. · PARMAR KUSH · 5AM Ventures VI, L.P. · 5AM Partners VI, LLC 10% owner / 10% owner / 10% owner / 10% owner | 2 derivative holdings | ▾ |
| Jul 18, 2024 | Miralles Gines Diego Director | 2 derivative holdings | ▾ |
| Jul 18, 2024 | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% owner | 1 derivative holding | ▾ |
| Jul 18, 2024 | Stoppel Laura Director | No securities reported | ▾ |
| Jul 18, 2024 | GC Corp. · GC Cell Corp 10% owner / 10% owner | 2 stock holdings · 4 derivative holdings | ▾ |
| Jul 18, 2024 | HOUGEN ELIZABETH L Director | 2 derivative holdings | ▾ |
| Jul 18, 2024 | DANIELS BRIAN Director | No securities reported | ▾ |
| Jul 18, 2024 | Raymon Heather SVP, Research and Development | 5 derivative holdings | ▾ |
| Jul 18, 2024 | Huh Yong-Jun Director | 2 stock holdings · 4 derivative holdings | ▾ |
| Jul 18, 2024 | Bessen Laura Director | 2 derivative holdings | ▾ |
| Jul 18, 2024 | Graef Thorsten Chief Medical Officer | 2 derivative holdings | ▾ |
| Jul 18, 2024 | Krishnamohan Neha Chief Financial Officer | 1 derivative holding | ▾ |
| Jul 18, 2024 | Horan Christopher Chief Tech Operations Officer | 3 derivative holdings | ▾ |
| Jul 18, 2024 | Bush Jennifer COO, CLO, Secy, Compliance Off | 22.80K shares · 4 derivative holdings | ▾ |
| Jul 18, 2024 | Aslan Fred President and CEO · Director | 5 derivative holdings | ▾ |
| Jul 18, 2024 | GOODMAN COREY S · Adelman Robert J · venBio Global Strategic Fund III, L.P. · VENBIO GLOBAL STRATEGIC GP III, LTD · VENBIO GLOBAL STRATEGIC GP III, L.P. 10% owner / 10% owner / 10% owner / 10% owner / 10% owner | 2 derivative holdings | ▾ |
Showing 18 / 18 statements in 2024. The complete set is available through the API.
Follow the people behind the trades.
Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.
- Download CSV
- Earlier filings
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For 2024, this page lists 18 of 18 statements.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.
MCP https://api.akkrudata.ai/mcp
akkru_initial_holdings
{"action":"list","ticker":"ARTV","page_size":20}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP / CLI documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.